JEFFREY S. ARONIN

Chairman and CEO

 

As Chairman and CEO of Paragon Biosciences, Jeffrey Aronin has launched several successful portfolio companies, including: Harmony Biosciences, Castle Creek Pharma, Emalex Biosciences, and Skyline Biosciences. Previously, Mr. Aronin served as President and CEO of Ovation Pharmaceuticals, which he founded in 2000 and was acquired by Lundbeck in 2009.

In multiple therapeutic areas, Mr. Aronin’s companies have earned more new drug approvals from the FDA than any other pharmaceutical company in the world during the past 10 years.

Mr. Aronin’s expertise in novel drug development and venture innovation has made him one of the most impactful and successful leaders in the biosciences sector. Mr. Aronin has transformed the lives of people treated for: complex partial seizures, tonic-clonic seizures, mixed seizure patterns, infantile spasms, Lennox-Gastaut syndrome, Porphyria, Duchenne muscular dystrophy, and Huntington's disease.

Insights Care Magazine recently recognized Mr. Aronin as one of the most influential leaders in healthcare for his extraordinary track record at improving the quality of life of patients with severe diseases, by developing breakthrough medicines to treat those conditions. To do so, Mr. Aronin and his team identify debilitating conditions which may be better treated with a promising drug compound—and then form and incubate biopharmaceutical companies to develop those therapies. That approach has attracted the healthcare industry’s most respected investors. For example, Mr. Aronin led the $295 million initial equity raise for Harmony Biosciences, which was the largest private equity financing of a privately-held North American biopharmaceutical company in 2017.

Mr. Aronin also devotes extensive energy to civic and philanthropic endeavors. As founder and co-chairman of MATTER—a health-technology startup incubator—Mr. Aronin has led one of Chicago’s most remarkable venture innovation successes, with over 200 healthcare companies founded and grown over the past five years. Mr. Aronin also serves on several non-profit and civic boards, including the executive committee of World Business Chicago.

As a believer in education as a change agent, Mr. Aronin serves as a mentor to students and young professionals and is also a frequent lecturer at the University of Chicago’s Booth School of Business and Northwestern University’s Kellogg School of Business.

Through the Aronin Family Foundation, Jeffrey and his wife Lisa provide millions of dollars in funding for patient support, scientific research, and education.